Cross Country HealthcareCCRN 53 Return-on-Tangible-Equity is -7.51% as of Mar. 2026. GuruFocus rates CCRN with a GF Score™ of 53/100 and a GF Value™ of $10.43 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 579 Healthcare Providers & Services companies, Cross Country Healthcare ranks worse than 87.05% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Cross Country Healthcare's annualized net income for the quarter that ended in Mar. 2026 was $-17 Mil. Cross Country Healthcare's average shareholder tangible equity for the quarter that ended in Mar. 2026 was $227 Mil. Therefore, Cross Country Healthcare's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -7.51%.
The historical rank and industry rank for Cross Country Healthcare's Return-on-Tangible-Equity or its related term are showing as below:
CCRN'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -223.72 Med: -5.6 Max: 240.62
Current: -41.98
During the past 13 years, Cross Country Healthcare's highest Return-on-Tangible-Equity was 240.62%. The lowest was -223.72%. And the median was -5.60%.
CCRN's Return-on-Tangible-Equity is ranked worse than 87.05% of 579
companies
in the Healthcare Providers & Services industry
Industry Median: 10.13
vs CCRN: -41.98
Cross Country Healthcare (NAS:CCRN) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Cross Country Healthcare Return-on-Tangible-Equity Related Terms
Cross Country Healthcare Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Cross Country Healthcare's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cross Country Healthcare Return-on-Tangible-Equity Chart
CCRN vs SRTA, CYH, AUNA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Cross Country Healthcare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cross Country Healthcare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cross Country Healthcare's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Cross Country Healthcare's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -7.51% mean?
Cross Country Healthcare (CCRN) has a Return-on-Tangible-Equity of -7.51% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Cross Country Healthcare and its competitors. According to the industry distribution chart, Cross Country Healthcare ranks #504 out of 579 companies in the Healthcare Providers & Services industry, placing it in the top 87%.
Is Cross Country Healthcare's Return-on-Tangible-Equity too high?
Cross Country Healthcare's current Return-on-Tangible-Equity is -7.51%. Based on the distribution chart, Cross Country Healthcare ranks #504 out of 579 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cross Country Healthcare has a GF Score™ of 53/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cross Country Healthcare's Return-on-Tangible-Equity compare to SRTA and CYH?
According to the Healthcare Providers & Services industry distribution chart, Cross Country Healthcare ranks #504 out of 579 companies for Return-on-Tangible-Equity. This places Cross Country Healthcare in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.13, based on 579 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Cross Country Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cross Country Healthcare's current Return-on-Tangible-Equity is -7.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cross Country Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Cross Country Healthcare (CCRN) is currently considered Modestly Overvalued. The stock's GF Value™ is $10.43, compared to a current price of $13.20 — trading 26.6% above its estimated fair value. The current Return-on-Tangible-Equity is -7.51%. Cross Country Healthcare's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Cross Country Healthcare (CCRN), the current Return-on-Tangible-Equity is -7.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cross Country Healthcare (CCRN) Overvalued in 2026?
Based on GuruFocus' analysis, Cross Country Healthcare stock appears to be overvalued.
The current stock price of $13.20 is trading 26.6% above its estimated GF Value™ of $10.43.
GuruFocus considers Cross Country Healthcare to be Modestly Overvalued.
Key valuation signals for CCRN:
Return-on-Tangible-Equity: -7.51%
GF Value™: $10.43 vs. price of $13.20 (26.6% above fair value)
No single metric tells the full story. See the CCRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
53GF Score
Get the complete analysis for CCRN
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CCRN has been successfully added to your 
